Another group has also reported that MMP13 proves to be a successful diagnostic tool for differentiating SCC and benign hyperkeratotic lesions in RDEB as MMP13 appears to have very high expression in SCC lesions [104]. This evidence concerns the gene MMP13 and recessive dystrophic epidermolysis bullosa.